X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4) 4
female (3) 3
humans (3) 3
male (3) 3
therapy (3) 3
cancer (2) 2
chemotherapy (2) 2
disease-free survival (2) 2
efficacy (2) 2
expression (2) 2
kaplan-meier estimate (2) 2
life sciences (2) 2
mesh: disease-free survival (2) 2
mesh: female (2) 2
mesh: humans (2) 2
mesh: male (2) 2
mutation (2) 2
oncology (2) 2
[ sdv.imm.ii ] life sciences [q-bio]/immunology/innate immunity (1) 1
[sdv.can]life sciences [q-bio]/cancer (1) 1
[sdv.imm.ii]life sciences [q-bio]/immunology/innate immunity (1) 1
abridged index medicus (1) 1
activation (1) 1
acute myeloid leukemia (1) 1
adult (1) 1
advanced phase cml (1) 1
aged (1) 1
aminoglycosides (1) 1
aminoglycosides - adverse effects (1) 1
aminoglycosides - therapeutic use (1) 1
analysis (1) 1
antibodies (1) 1
antibodies, monoclonal, humanized (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antineoplastic agents (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
apoptosis (1) 1
azacitidine - administration & dosage (1) 1
azacytidine (1) 1
biochemistry (1) 1
biomarkers (1) 1
blast crisis (1) 1
bone marrow (1) 1
breast-cancer cells (1) 1
cell cycle proteins (1) 1
cell cycle proteins - genetics (1) 1
cell cycle proteins/genetics (1) 1
cell death (1) 1
cell research (1) 1
chronic myeloid-leukemia (1) 1
clinical trials (1) 1
combined modality therapy (1) 1
cpg islands (1) 1
cytogenetic analysis (1) 1
dasatinib (1) 1
daunorubicin (1) 1
diagnosis (1) 1
dna methylation (1) 1
dna mutational analysis (1) 1
docosahexaenoic acid (1) 1
drug dosages (1) 1
f-box proteins (1) 1
f-box proteins - genetics (1) 1
f-box proteins/genetics (1) 1
f-box-wd repeat-containing protein 7 (1) 1
follow-up (1) 1
gemtuzumab ozogamicin (1) 1
gene deletion (1) 1
genes (1) 1
genetic predisposition to disease (1) 1
growth (1) 1
gtp phosphohydrolases (1) 1
gtp phosphohydrolases - genetics (1) 1
gtp phosphohydrolases/genetics (1) 1
hematology (1) 1
hematopoietic stem cell transplantation (1) 1
imatinib-resistant (1) 1
immunoconjugate (1) 1
immunology (1) 1
increases (1) 1
induction (1) 1
innate immunity (1) 1
internal medicine (1) 1
intravenous administration (1) 1
leukemia, myeloid, acute (1) 1
leukemia, myeloid, acute - drug therapy (1) 1
leukemia, myeloid, acute - mortality (1) 1
leukemia, myeloid, chronic-phase - diagnosis (1) 1
leukemia, myeloid, chronic-phase - drug therapy (1) 1
leukemia, myeloid, chronic-phase - mortality (1) 1
lymphocytic-leukemia (1) 1
medicine, general & internal (1) 1
membrane proteins (1) 1
membrane proteins - genetics (1) 1
membrane proteins/genetics (1) 1
mesh : adult (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9825, pp. 1508 - 1516
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2013, Volume 31, Issue 34, pp. 4333 - 4342
Journal Article
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 2776 - 2776
Abstract Background: Patients undergoing treatment for acute lymphoblastic leukemia (ALL) are at risk for thrombosis, in part due to the use of L-asparaginase... 
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 21, pp. 881 - 881
Abstract Abstract 881 T-cell acute lymphoblastic leukemia (T-ALL) represents a heterogeneous group of acute leukemias, which account for 25% of adult ALL. The... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.